AbbVie ends 11-year Calico partnership focused on aging research
FierceBiotech - 12-Nov-2025AbbVie ends its $1.75B Calico deal after the ALS drug fosigotifator failed in phase 2/3 trials
Investments News
Lilly expands $100M AI drug discovery deal with Insilico Medicine
Longevity Technology - 11-Nov-2025Insilico’s AI cut drug discovery to 18 months, spurring Lilly’s investment
Inbrain teams with Microsoft to advance AI-powered brain implants
FierceBiotech - 11-Nov-2025Graphene-based BCIs use Azure AI to adapt in real time for Parkinson’s and stroke therapy
Synchron raises $200M to advance thought-controlled tech
MobiHealthNews - 06-Nov-2025Funding accelerates Stentrode’s clinical progress and hands-free device control for paralysis
Chan and Zuckerberg shift philanthropy toward AI-driven biomedical research
Independent - 06-Nov-2025Biohub will invest ~$1B a year to build AI-driven virtual cells and speed disease research
Roche taps Manifold Bio to cross the brain barrier
FierceBiotech - 03-Nov-2025$2B deal aims to develop AI-guided shuttles to carry therapies across the blood-brain barrier
Cyclana Bio: redefining women’s health
Longevity Technology - 30-Oct-2025Using menstrual fluid, Cyclana builds tissue models to tackle endometriosis and chronic inflammation
Mission raises $13.3m for Parkinson’s mitophagy drug
Longevity Technology - 27-Oct-2025Cambridge biotech to trial USP30 inhibitor MTX325 to boost mitochondrial repair in Parkinson’s
Accel backs longevity startup Generation Lab
Fortune - 23-Oct-2025Startup aims to add 20 healthy years through advanced epigenetic age testing
Elevara raises $70M to tackle rheumatoid arthritis
Longevity Technology - 23-Oct-2025Biotech startup Elevara aims to transform RA treatment with a non-immunosuppressive oral drug
Major board shake-up at Novo Nordisk amid leadership clash
The Guardian - 21-Oct-2025Wegovy maker faces leadership overhaul after dispute with its largest shareholder
Eli Lilly backs NewLimit’s $45m push toward cellular rejuvenation
Longevity Technology - 21-Oct-2025NewLimit’s $45M raise advances youthful liver and immune cell restoration in preclinical studies
Pelage secures $120M to advance stem cell hair loss therapy
Longevity Technology - 17-Oct-2025PP405 shows early promise in reactivating dormant hair follicles to restore growth
Takeda partners with Nabla Bio to speed up drug discovery using AI
FierceBiotech - 14-Oct-2025Their goal is to make treatments faster, safer, and more effective
Biotech’s comeback looks built to last
The Wall Street Journal - 13-Oct-2025Easing regulations and new drug approvals fuel optimism for a sustained biotech rally
Kneu Health created an AI-powered phone app to detect early signs of brain decline
Longevity Technology - 09-Oct-2025Trials showed fewer hospital visits and faster access to care
The Cat Health Company raises $1.2m to extend feline healthspan
Longevity Technology - 08-Oct-2025Interim trials show improved weight, muscle, and vitality in aging cats with TCHC therapies
AI meets CRISPR: Algen and AstraZeneca join forces in $555m gene discovery deal
Longevity Technology - 06-Oct-2025Partnership aims to uncover disease-driving genes and boost precision drug development
Gene therapy startup aims to reverse retinal aging to restore vision
Longevity Technology - 03-Oct-2025Cirrus Therapeutics targets aging biology to combat blindness from dry AMD
Until Labs raises $58M to push boundaries of cryopreservation
Longevity Technology - 23-Sep-2025Startup scaled cryopreservation from neural slices to large-animal organs, eyeing human trials
Oura ring maker secures $875M, valued at nearly $11B
TechCrunch - 22-Sep-2025Oura doubles valuation to $10.9B after selling 5.5M rings and projecting $1B+ revenue in 2025
Bio Protocol raises $6.9M to scale AI-native DeSci biotech platform
Longevity Technology - 19-Sep-2025First BioAgent generated 1,000+ hypotheses, raised $900K, and drove lab testing within weeks
Ronovo secures $67M to expand modular robotic surgery platform
FierceBiotech - 09-Sep-2025Backed by J&J, Carina robot gains traction in China with global approvals on the horizon
Revalia Bio raises $14.5M to advance human organ-based drug testing
Longevity Technology - 09-Sep-2025Using donated organs, Revalia aims to cut drug failures and speed safe treatments to patients
NRG raises $67M for mitochondrial drugs in neurodegeneration
Longevity Technology - 08-Sep-2025Funding backs trials of NRG5051, aiming to slow ALS and Parkinson’s by protecting neurons
Display all news
